0001968582-23-000406.txt : 20230815
0001968582-23-000406.hdr.sgml : 20230815
20230815172454
ACCESSION NUMBER: 0001968582-23-000406
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 231175851
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lalwani Nikhil
CENTRAL INDEX KEY: 0001822629
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ANI PHARMACEUTICALS, INC.
STREET 2: 210 MAIN STREET
CITY: BAUDETTE
STATE: MN
ZIP: 56623
144
1
primary_doc.xml
144
0001822629
XXXXXXXX
LIVE
0001023024
ANI Pharmaceuticals, Inc.
001-31812
210 Main Street West
Daudette
MN
56623
218-634-3500
Nikhil S. Lalwani
President, CEO
Common
JP Morgan Securities LLC
390 Madison Avenue
6th Floor
New York
NY
10017
11616
708344
20280798
08/15/2023
NASDAQ
Common
08/15/2023
Stock Option Exercise
Issuer
N
11616
08/15/2023
Cash
N
Nikhil S. Lalwani
C/o ANI Pharmaceuticals, Inc.
210 Main Street West
Daudette
MN
56623
Common
08/11/2023
56666
3272462
The options to be exercised within 3 months from the date of this filing.
08/15/2023
/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Nikhil S. Lalwani